ReportWire

Tag: health news

  • Losing a Family Pet Gives Parents a Chance to Teach Children About Death and Grieving

    Losing a pet is the first time many children encounter death. The experience can become an opportunity for profound emotional learning and influence how young people understand and process grief when they are adults, according to psychologists and pet bereavement specialists.

    Parents and guardians therefore have important roles to play when a family pet dies. Along with helping children accept the painful permanence of death, caregivers can guide kids through a healthy and healing mourning process that provides a foundation for coping with an inevitable part of life.

    “People are so adverse to talking about death and grief, but it is the one thing that is guaranteed: We are all going to die. We need to be open to talking about that,” said Deirdra Flavin, CEO of the National Alliance for Children’s Grief.

    Here are some things to consider when talking with children about death and supporting them through pet loss.


    Children respond to death in different ways

    Depending on how old they are and their individual circumstances, children vary in their ability to comprehend the concept of death. The way they process grief, how long they mourn and the impact of the loss is also unique to each child, just as it is for adults. Experts say sadness, anger and other overwhelming emotions associated with grief may be more difficult for younger children to navigate, so having support is crucial.

    Psychologists and bereavement counselors say some people feel the heartbreak from a pet’s death as intensely as the loss of any other loved one, reflecting the potential depths of human-animal bonds. In the case of children, their relationship with a pet, and whether the death was sudden or not, are other factors that may shape individual responses.

    Colleen Rolland, president of the Association for Pet Loss and Bereavement, says parents usually know how intellectually and emotionally capable their children are of processing death.

    Children as young as 4 years old might have been exposed to death through fairy tales and other stories but may struggle to understand its finality, Rolland said. Older children, who will know their loss is forever, may need more emotional support from friends and family, she said.

    Elizabeth Perez said she learned quickly how differently her three children processed the death of their dog, Zoe, who was hit by a car nearly a year-and-a-half ago in front of their second daughter. The other two children were inside the family’s home in Pullman, Washington.

    “Carmen would talk about how the images kept replaying in her head, she was having nightmares and couldn’t sleep,” Perez said, adding that her daughter hasn’t worn the dress she had on that day since.

    Perez recalls she and her husband spending a lot of time with Carmen, now 11, and asking her questions about her feelings. Even their youngest child, who did not see the car hit Zoe and had spent the least amount of time with the dog, still tears up thinking about the April 2024 accident.

    “It was really hard for the whole family. Everybody was feeling it differently and at different times,” Perez said. “We, as parents, did not feel prepared.”


    Using clear language and avoiding euphemisms

    Experts say it’s important to be honest and use clear language when discussing death with children. Adults often are inclined to protect children with euphemisms, such as a pet went to sleep, got lost or was put down.

    “That can be alarming for children and cause a lot of confusion and fear. So, saying ‘The fish went to sleep’ might create concerns for the child when they are going to sleep,” Flavin said. “Particularly with younger kids because they are so literal in terms of the way that things are expressed to them.”

    When Leah Motz’s daughter was 2 years old, she told her their 15-year-old dog, Izzy, had a “good life but his body is broken and it won’t be able to fix itself.” Motz recalled that before taking him to be euthanized near their home in Renton, Washington, she further explained they were going to “help Izzy die.”


    Support children through deep feelings

    Sometimes adults have a hard time recognizing the impact that losing a pet instead of a person might have on children. Rolland says child grief tends to be trivialized in general, and that people who are very devoted to their pets can produce as much stigma as sympathy.

    “But pet loss is a very real form of grief,” she said.

    Raquel Halfond, a licensed clinical psychologist with the American Psychological Association, says children’s behavior often indicates how they are feeling even if they are not expressing it verbally.

    “Maybe you notice your child is having more tantrums. Suddenly there’s stuff that they used to love doing, they no longer want to do. Maybe they start to refuse to go to school. It’s really normal to have these for a while,” Halfond said.

    Other signs to look for include uncharacteristic sadness, tears, anger and even silence, she said. A child’s emotional response is often independent of their willingness to talk about death, but she said it might be time to seek professional help if their emotions or behavior affect their ability to function.


    It’s OK for adults to grieve with children

    Much like they do in other situations or developmental stages, children often learn how to handle grief by watching their caregivers. The way adults respond to loss is likely to set an example for their children.

    “Parents, or caregivers, must be confident in how they deal with pet loss,” Rolland said, adding that parents who are unfamiliar with grief or display unhealthy behaviors might teach children to act in the same manner.

    Two of Meaghan Marr’s dogs died in Euharlee, Georgia, when her two children were young. The first to go, Sadie, had ongoing health issues, so Marr was able to have continuous conversations and prepare her then-7-year-old son and 4-year-old daughter.

    “My son definitely understood what was going on. While my daughter was sad, it didn’t quite reach her as deeply,” Marr said. She said it seemed like a lot of the children’s’ emotions were in response to her own grieving for a pet she refers to as her “soulmate dog.”

    Halfond advises parents not to hide their feelings from their children.

    “If you’re feeling sad, it’s OK for the child to see you feeling sad. In fact, it could be confusing if something sad happened and they don’t see that emotion reflected in their parents,” she said.


    Leave room for closure and lifelong memories

    One way to help children come to terms with the death of a pet is by memorializing the lives of the late companions through activities such as raising money for animals in need, drawing pictures, holding funerals or doing the things their pets loved to do.

    Before their dog Sadie died, Marr said many of the conversations with her kids centered around how dogs don’t live forever and would one day go to heaven. The difficult part for her was explaining that was true of every pet.

    “We talked about if they still wanted animals even though they are not going to last as long as we do,” she said. “It hurts to lose them, but they make your life so much better while they are here.”

    Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Photos You Should See – Oct. 2025

    Associated Press

    Source link

  • More Than 80% of Health Facilities in Eastern Congo Are Out of Medicine, Red Cross Says

    KINSHASA, Congo (AP) — Over 200 health facilities in eastern Congo are experiencing shortages of medicines as a result of fighting in the region and a lack of humanitarian funding, the International Committee of the Red Cross said Wednesday.

    The Red Cross said it assessed 240 health centers and clinics in North and South Kivu, two provinces where the Rwanda-backed M23 rebels made an unprecedented advance earlier this year, further deepening one of the world’s largest humanitarian crises.

    The difficulties in crossing front lines in the war-hit regions have prevented health facilities from getting access to medicine, even when it is available, the ICRC said.

    “The lives of thousands of people are at stake,” due to the shortage of essential medicine against malaria, HIV, tuberculosis, and other diseases, François Moreillon, the head of the ICRC’s delegation in Congo, said during a news conference Wednesday.

    Many humanitarian organizations supporting health facilities in the region have been forced to reduce their work or shutdown because of a lack of funding, he added.

    “Currently, more than 80 per cent of health facilities in the Kivu provinces receive no support from humanitarian partners and are only operational thanks to the remarkable commitment of their staff on both sides of the front lines,” Moreillon said.

    Many health workers have also fled the war-torn regions, leading to staff shortages in almost half of the facilities assessed by the ICRC, according to the organization.

    Congo’s mineral-rich east has long been battered by fighting involving more than 100 armed groups including the Rwanda-backed M23 rebels. The rebels seized the provincial capitals Goma and Bukavu earlier this year, escalating the decades-old conflict.

    The rebels’ advance has killed some 3,000 people this year and worsened what was already one of the world’s largest humanitarian crises, with around 7 million people displaced. While fighting has largely decreased as a result of peace efforts, there are still clashes and civilians are still being killed.

    Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Photos You Should See – Sept. 2025

    Associated Press

    Source link

  • CDC Leaves COVID Vaccination Up to Patients

    TUESDAY, Oct. 7, 2025 (HealthDay News) — The U.S. Centers for Disease Control and Prevention (CDC) has dropped its recommendation that all Americans receive routine COVID-19 shots, leaving the decision up to patients and doctors.

    The shift follows new guidance from a panel of vaccine advisers appointed by U.S. Health Secretary Robert F. Kennedy Jr., who fired the CDC’s longstanding vaccine advisory group earlier this year. 

    Until now, the CDC had recommended annual COVID boosters for everyone 6 months and older.

    But the new panel — created by Kennedy, who has publicly questioned vaccine safety — voted last month to remove that recommendation. The CDC signed off on the change this week.

    “Informed consent is back,” Interim CDC Director Jim O’Neill said as he approved the move.

    “Past guidance deterred health care providers from talking about the risks and benefits of vaccination,” he said.

    However, some doctors criticized the statement, noting that informed consent has always been part of the vaccine process.

    “To make a statement that informed consent is back implies that it had gone away. In no way has it gone away,” Dr. Jesse Hackell, a retired New York pediatrician who has coauthored several American Academy of Pediatrics vaccine policies, told The Associated Press.

    Major medical organizations continue to recommend COVID-19 vaccines for pregnant women, children and adults at higher risk of serious illness. 

    They argue that the administration’s new stance could mislead the public about vaccine safety, which has been proven in billions of doses given worldwide.

    The CDC also said patients, especially older adults, should consult with their doctors, nurses or pharmacists about whether vaccination is right for them.

    Further, the decision also clears the way for the government’s Vaccines for Children program to continue offering free COVID shots to eligible families.

    In a separate update, the CDC also accepted a panel recommendation that children under age 4 receive their first chickenpox (varicella) shot separately from the combined measles, mumps, rubella and varicella (MMRV) vaccine. 

    Research has shown that the combination shot carries a higher risk of fever and related seizures.

    Since 2009, the CDC has preferred giving these shots separately for first doses, and about 85% of toddlers already receive the varicella vaccine on its own, the agency said.

    SOURCE: The Associated Press, Oct. 6, 2025

    Copyright © 2025 HealthDay. All rights reserved.

    HealthDay

    Source link

  • Babies More Likely To Die If Mother Passes During Or After Pregnancy

    By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 7, 2025 (HealthDay News) — Protecting newborns’ lives starts with protecting the health of an expecting mother, a new study says.

    Infants are 14 to 22 times more likely to die if their mother dies during pregnancy or just after delivering a newborn, researchers reported recently in the journal Obstetrics & Gynecology.

    “If we want to protect infant health, the first step is to recognize the shared health outcomes between mothers and their infants,” said lead researcher Eugene Declercq, a professor of community health sciences at Boston University School of Public Health.

    “Improving women’s health is a worthy goal in itself, but this research reminds us that healthier mothers are also the foundation for protecting the health of their infants and, ultimately, their families,” Declercq said in a news release.

    For the new study, researchers tracked more than 1.6 million live births that occurred in Massachusetts between 1999 and 2020. Among them, there were 474 pregnancy-related deaths.

    The infant death rate was more than 14 times higher when a mother died during pregnancy or following delivery, researchers found.

    Infants’ death rate increased higher if maternal deaths occurred following severe health problems during pregnancy. In those cases, infants’ death rate was 22 times greater.

    Even babies born at term who survived their mother’s pregnancy-related death were still 35% more likely to be hospitalized within their first year of life, results showed.

    The overall pregnancy-associated maternal death rate in Massachusetts was more than 29 deaths per 100,000 live births.

    When moms died, the infant death rate was 55 for every 1,000 live births, researchers found.

    The infant death rate rose to nearly 88 deaths per 1,000 live births if a mother died after suffering a pregnancy-related health problem like kidney failure, high blood pressure, eclampsia or sepsis.

    And these results might actually be sunny compared to the rest of the nation, researchers said. During this period, Massachusetts had the lowest infant death rate in the U.S.

    These results come during a politically motivated push to reduce or eliminate maternal mortality review committees operating in some states where mothers’ death rates are higher, researchers said.

    Georgia, Texas and Arkansas all have taken steps to limit their review committees, to prevent review of how abortion bans or Medicaid policies might affect the maternal death rate, Stateline reports.

    The U.S. currently has the highest maternal death rate of any developed nation, with more than 22 deaths for every 100,000 live births in 2022, according to the Commonwealth Fund.

    By comparison, New Zealand has nearly 14 deaths per 100,000 live births, Canada more than 8 per 100,000, France more than 7 per 100,000, the U.K. fewer than 6 per 100,000 and Germany, Austria and Japan fewer than 4 per 100,000.

    “Pregnancy-associated death is a tragedy in and of itself, but its consequences can extend to a family and community,” the research team concluded in its paper.

    “This research suggests the need to broaden the scope of the U.S. maternal mortality crisis to emphasize the importance of protecting maternal health to preserve infant health,” researchers wrote.

    SOURCES: Boston University, news release, Sept. 26, 2025; Obstetrics & Gynecology, journal, Sept. 25, 2025

    Copyright © 2025 HealthDay. All rights reserved.

    HealthDay

    Source link

  • USDA Warns That Hello Fresh Meals May Contain Listeria-Tainted Spinach

    Federal health officials late Monday warned people not to eat certain Hello Fresh subscription meal kits containing spinach that may be contaminated with listeria.

    The U.S. Agriculture Department issued a public health alert for the meals, which were produced by FreshRealm, the San Clemente, California-based company linked to an expanding listeria outbreak tied to heat-and-eat pasta meals.

    The products include 10.1-ounce containers of Hello Fresh Ready Made Meals Cheesy Pulled Pork Pepper Pasta and 10-ounce containers of Hello Fresh Ready Made Meals Unstuffed Peppers with Ground Turkey. Both were shipped directly to consumers.

    The pork pepper pasta is identified with establishment number Est. 47718 and lot code 49107 or Est. 2937 and lot code 48840. The unstuffed peppers with ground turkey is identified with Est. P-47718 and lot codes 50069, 50073 or 50698.

    The problem was discovered when FreshRealm notified the USDA’s Food Safety and Inspection Service that the spinach used in the products tested positive for listeria bacteria.

    Last month, FreshRealm said that tests confirmed that pasta used in linguine dishes sold at Walmart contained the same strain of listeria linked to an outbreak in June. That outbreak, originally tied to chicken fettucine Alfredo, has killed at least four people and sickened 20, with the most recent illness reported Sept. 11.

    FreshRealm officials said genetic testing found the outbreak strain of listeria in samples of pasta made and supplied by Nate’s Fine Foods of Roseville, California.

    Several additional companies including Kroger, Giant Eagle and Albertson’s have recalled pasta salads and other dishes made with products from Nate’s Fine Foods for potential listeria contamination.

    Listeria infections can cause serious illness, particularly in older adults, people with weakened immune systems and those who are pregnant or their newborns. Symptoms include fever, muscle aches, headache, stiff neck, confusion, loss of balance and convulsions.

    About 1,600 people get sick each year from listeria infections and about 260 die, the CDC says. Federal officials in December said they were revamping protocols to prevent listeria infections after several high-profile outbreaks, including one linked to Boar’s Head deli meats that led to 10 deaths and more than 60 illnesses last year.

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

    Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Photos You Should See – Sept. 2025

    Associated Press

    Source link

  • Costco is selling weight-loss drugs Ozempic, Wegovy at discounted prices

    Costco now is selling Ozempic and Wegovy at discounted prices, a move that expands access to the popular weight-loss drugs.

    Costco members with prescriptions can purchase the drugs out-of-pocket for $499 per month, a cost that is well below list prices. For members with health insurance, the price will depend on their plans. The sticker price for Ozempic is about $1,000; Wegovy costs $1,350.


    MORE: Long-term study on HPV vaccinations finds evidence of herd immunity


    Novo Nordisk, the Danish company that manufacturers Ozempic and Wegovy, already offers the drugs at $499 on its website, and also at CVS and Walmart. 

    “We want to make sure we offer the real, authentic Wegovy and Ozempic where patients seek care,” David Moore, executive vice president of Novo Nordisk’s U.S. Operations, told NBC News on Friday. “We know that Costco is a trusted brand.

    “Those patients that have coverage will receive the medicine on average for $25 a month,” Moore added. “But that doesn’t cover everyone, so we wanted to make sure there’s a self-pay option available as well.” 

    A Novo Nordisk spokesperson said Monday that Costo’s executive members and customers with a Costco Citibank Visa credit card also will receive a cash back reward and an additional 2% discount when purchasing the drugs. 

    Costco did not immediately respond to a request for comment. 

    Ozempic and Wegovy are GLP-1 drugs, a classification that also includes Zepbound, a medication made by Eli Lilly. They help people lose weight by mimicking a hormone known as glucagon-like peptide 1 that slows digestion, regulates blood sugar and signals fullness to the brain. 

    Ozempic was approved as a diabetes drug; Wegovy and Zepbound were approved to treat obesity. But they have been used off label to help people lose weight. Studies also have suggested they may have additional health benefits, including reducing risk of heart disease, dementia and addiction to alcohol or nicotine.

    The demand for the drugs has skyrocketed in recent years ago. A 2024 survey found 1 in 8 adults said they have used a GLP-1 drugs. With so many people using the drugs, insurers say they have struggled to cover the costs, because the drugs must be taken indefinitely to maintain weight loss and other health benefits. 

    The Trump administration plans to roll out a five-year, experimental program that would allow state Medicaid programs and Medicare Part D plans to cover GLP-1 agonists for weight loss. Some state Medicaid programs, including those in Pennsylvania and New Jersey, cover the drugs for obesity, and Medicare covers them for diabetes. 

    Molly McVety

    Source link

  • FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis

    By Lori Solomon HealthDay ReporterTHURSDAY, Oct. 2, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of plaque psoriasis and active psoriatic arthritis in children 6 years of age and older.

    The approval is for pediatric patients living with either moderate-to-severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, or active psoriatic arthritis. This approval expands indications of use beyond the initial adult population and is the first and only pediatric approval for an interleukin-23 inhibitor.

    The approval is based on results from the phase 3 PROTOSTAR study in which the coprimary end points of Psoriasis Area Severity Index (PASI) 90 and Investigator’s Global Assessment (IGA) score of 0/1 were achieved at week 16. More than half of patients (56 percent) receiving Tremfya achieved PASI 90 versus 16 percent of patients receiving placebo. For IGA score, at week 16, two-thirds (66 percent) of patients receiving Tremfya achieved high levels of skin clearance (score 0/1) versus 16 percent of patients receiving placebo. Complete clearance (IGA 0) at week 16 was achieved by nearly 40 percent of pediatric patients receiving Tremfya versus 4 percent on placebo.

    “Despite advancements in the treatment of pediatric plaque psoriasis and active psoriatic arthritis, there continues to be a significant gap in available therapies for these debilitating immune-mediated diseases that impact a child’s physical and emotional well-being during critical years,” study investigator Vimal Hasmukh Prajapati, M.D., from the University of Calgary in Alberta, Canada, said in a statement. “The approval of Tremfya offers physicians, as well as parents and care partners, an established treatment option with proven safety and demonstrated efficacy that can significantly improve the signs and symptoms in children living with these diseases.”

    Approval of Tremfya was granted to Johnson & Johnson.

    Copyright © 2025 HealthDay. All rights reserved.

    HealthDay

    Source link

  • Home Bakers Donate Fresh Bread to Food Banks Thanks to This Seattle Nonprofit

    On a recent Saturday near Seattle, Cheryl Ewaldsen pulled three golden loaves of wheat bread out of her kitchen oven.

    The fragrant, oat-topped bread was destined not for her table, but for a local food bank, to be distributed to families increasingly struggling with hunger and the high cost of groceries.

    “I just get really excited about it knowing that it’s going to someone and they’re going to make, like, 10 sandwiches,” said Ewaldsen, 75, a retired university human resources director.

    Ewaldsen is a volunteer with Community Loaves, a Seattle-area nonprofit that started pairing home bakers with food pantries during the COVID-19 pandemic — and hasn’t stopped.

    Since 2020, the organization headed by Katherine Kehrli, the former dean of a culinary school, has donated more than 200,000 loaves of fresh bread and some 220,000 energy cookies to food banks. They come from a network of nearly 900 bakers in four states — Washington, Oregon, California and Idaho — and represent one of the largest such efforts in the country.

    “Most of our food banks do not get any kind of whole-grain sandwich bread donation,” she said. “When we ask what we could do better, they just say, ‘Bring us more.’”


    Anti-hunger experts expect to see more need

    Ewaldsen’s bread goes to the nearby Edmonds Food Bank, where the client list has swelled from 350 households to nearly 1,000 in the past three years, according to program manager Lester Almanza.

    Nationwide, more than 50 million people a year receive charitable food assistance, according to Feeding America, a hunger relief organization.

    Gauging the impact, however, could soon be more difficult after the U.S. Agriculture Department recently said it would halt an annual report on hunger in America, saying it was redundant, costly and politicized “subjective liberal fodder.” After 30 years, the 2024 report, to be released on Oct. 22, will be the last, the agency said.

    “Ending data collection will not end hunger, it will only make it a hidden crisis that is easier to ignore and more difficult to address,” Crystal FitzSimons, president of the Food Research & Action Center, an advocacy group, said in a statement.

    Almanza said federal funding for his food bank has dropped at least 10% this year, meaning that every donation helps.

    “It’s something that a lot of people rely on,” he said.


    Food bank breads are often highly processed

    That includes people like Chris Redfearn, 42, and his wife, Melanie Rodriguez-Redfearn, 43, who turned to a food bank in Everett, Washington, last spring after moving to the area to find work. They had to stretch their savings until she began a new position this month teaching history at a local college. Chris Redfearn, who has worked for decades in business, is still looking.

    “The food pantry assists with anywhere from $40 to $80 worth of savings weekly,” he said. “We’ve been able to keep ourselves afloat.”

    Finding homemade bread from Community Loaves at a food pantry was a surprise, the couple said. Often, surplus bread sent by grocery stores includes highly processed white breads or sweets donated near their expiration or sell-by dates.

    The breads come in three varieties — honey oat, whole wheat and sunflower rye — all made with whole grains and minimally processed ingredients.

    “They make it really wholesome and fibrous,” Chris Redfearn said. “It mimics most of the health-conscious breads that are out there.”


    Many food banks don’t accept donated baked goods

    The notion of donating home-baked bread came to Kehrli, 61, during the pandemic, when she was displaced from her job at the busy Seattle Culinary Academy.

    “I love to bake and just an idea sparked: Would it be possible for us to help from our home and get important valuable nutrition to our food banks?” she recalled.

    Many food pantries don’t accept or distribute donations of homemade baked goods. Feeding America warns individual bakers against the practice, saying “since food banks can’t confirm how your baked goods were made or their ingredients, they can’t be donated.”

    But health department rules vary by state, Kehrli learned. In Washington and the other three states where Community Loaves now operates, bread is one of the few foods allowed to be donated from a home kitchen through a program like theirs.

    “We wouldn’t be able to donate custard pies. We wouldn’t be able to donate lasagna,” Kehrli said. “But bread is deemed safe. Anything that is fully baked and does not require refrigeration.”

    Still, Community Loaves bakers must follow approved recipes for the bread and two types of energy cookies. They obtain flour from common sources, and bake and deliver on a shared schedule twice a month.

    The bakers buy their own supplies, donating the cost of the ingredients as well as their time. Most make a few loaves per baking session before delivering them to local “hubs,” where other volunteers collect the bread and transport it to the food banks.

    Bakers range from former professionals to beginners. A robust website with recipes and how-to videos backstops every step, Kehrli said.

    Baking the bread is satisfying on several levels, said Ewaldsen, who has donated nearly 800 loaves in less than two years. Part of it is addressing the physical need for food, but part is also addressing the spiritual hunger for connection with neighbors.

    “It’s the opportunity for me to bake something and to share something with others in the community, where they don’t necessarily need to know who I am, but they know that there’s a community that loves and cares for them,” she said.

    While such sentiments are sincere and admirable, anti-hunger experts stress that individual donations can’t take the place of adequately funded government services for struggling Americans.

    “It’s beautiful that our communities act this way,” said Gina Plata-Nino of the Food Research & Action Center. “But it is a loaf of bread. That is going to feed one person — and there are millions in line.”

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

    Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Photos You Should See – Sept. 2025

    Associated Press

    Source link

  • Albertsons Recalls Several Deli Items Due to Potential Listeria Contamination

    NEW YORK (AP) — Albertsons Companies has recalled several of its store-made deli products because they may contain listeria bacteria, in a move that arrives shortly after federal health officials warned consumers to not eat certain pasta meals sold at Walmart and Trader Joe’s over similar contamination concerns.

    The Boise, Idaho-based supermarket giant on Saturday said it was pulling five deli items because they contain a recalled bowtie pasta ingredient made by Nate’s Fine Foods. Albertsons is urging consumers to not eat these products — which were supplied by refrigerated goods distributor Fresh Creative Foods — and is instructing those impacted to throw them away or initiate a return at their local store for a full refund.

    The products under recall include certain ready-to-eat basil pesto pasta salad offerings, as well as pasta dishes with chicken, spinach and other ingredients. Consumers can determine if an item they bought is impacted by looking at the list of product names, sell thru dates and other identifying information on Albertsons’ website.

    The recalled items were sold in various Albertsons-owned stores — including Albertsons Market, Safeway and Von’s — across more than a dozen states.

    “Listeria monocytogenes can survive in refrigerated temperatures and can easily spread to other foods and surfaces,” Albertsons warned in its release. The company also noted that the FDA instructs consumers to be extra vigilant when cleaning any surfaces or containers that may have come into contact with products recalled for possible listeria contamination.

    The Associated Press reached out to Nate’s Fine Foods in California and Fresh Creative Foods, a division of Oregon-based Reser’s Fine Foods, for further statements on Sunday.

    Albertsons on Saturday said that there had been no reports of injuries or illnesses related to its recalled products. But the company’s recall comes amid wider warnings from U.S. health officials about potential listeria contamination in ready-made meals sold by other retailers, some of which have previously been linked to a deadly outbreak.

    Last week, the U.S. Agriculture Department issued a public health alert warning consumers to not eat Trader Joe’s “Cajun Style Blackened Chicken Breast Fettuccine Alfredo” with best-by dates of Sept. 20, Sept. 24 and Sept. 27 — as well as “Marketside Linguine with Beef Meatballs & Marinara Sauce” sold at Walmart with best-by dates of Sept. 22 through Oct. 1, due to potential listeria contamination.

    No recall has been issued for either of those products, but Trader Joe’s in a company advisory urged consumers to discard or return its impacted chicken alfredo — and Walmart officials also said they put a stop on sales.

    Similar to the bowtie pasta recalled at Albertsons, the pasta in these goods came from Nate’s Fine Foods.

    Listeria infections can cause serious illness, particularly in older adults, people with weakened immune systems and those who are pregnant or their newborns. Symptoms include fever, muscle aches, headache, stiff neck, confusion, loss of balance and convulsions.

    Roughly 1,600 people in the U.S. get sick each year from listeria infections and about 260 die, per the Centers for Disease Control and Prevention.

    Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Photos You Should See – Sept. 2025

    Associated Press

    Source link

  • 58M Pounds of Corn Dogs and Sausage-On-A-Stick Products Recalled Because Wood Pieces May Be Inside

    NEW YORK (AP) — About 58 million pounds of corn dogs and other sausage-on-a-stick products are being recalled across the U.S. because pieces of wood may be embedded in the batter, with several consumers reporting injuries to date.

    According to a Saturday notice published by the Agriculture Department’s Food Safety and Inspection Service, the recall covers select “State Fair Corn Dogs on a Stick” and “Jimmy Dean Pancakes & Sausage on a Stick” products from Texas-based Hillshire Brands, which is a subsidiary of Tyson Foods.

    The contamination problem was discovered after Hillshire received multiple consumer complaints, the service notes, five of which involved injuries. The company later determined that a “limited number” of these products included “extraneous pieces of wooden stick within the batter,” Tyson said in a corresponding announcement — adding that it opted to initiate a recall “out of an abundance of caution.”

    The recalled corn dogs and sausage-on-a-stick goods were produced between March 17 and as recently Friday, per Saturday’s recall notices. Tyson, which is headquartered in Arkansas, says the issue was isolated to one facility located in Haltom City, Texas.

    FSIS is worried that some of these recalled products may be in consumers’ refrigerators and freezers in households across the U.S. — as well as some schools and other institutions. In addition to being sold online and to retailers nationwide, the agency noted Saturday, these products were also sold to school districts and Defense Department facilities.

    Consumers in possession of the now recalled “State Fair Corn Dogs on a Stick” and “Jimmy Dean Pancakes & Sausage on a Stick” are urged to throw them away or return them to their place of purchase.

    To determine which corn dogs and other sausage goods are subject to this recall, consumers should check the product’s name, use by dates and other identifying information published online by the FSIS and Tyson. The products being recalled should also have an establishment number of “EST-582” or “P-894” printed on the packaging.

    It’s unclear if consumers who purchased these now-recalled products will be eligible for a refund. The Associated Press reached out to contacts for Hillshire Brands and Tyson for further information Sunday.

    Foreign object contamination is one of the top reasons for food recalls in the U.S. Beyond plastic, metal fragments, bits of bugs and more “extraneous” materials have prompted recalls by making their way into packaged goods.

    Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Photos You Should See – Sept. 2025

    Associated Press

    Source link

  • Senior CDC officials resign after Susan Monarez’s ouster, citing concerns over scientific independence

    Four senior officials with the Centers for Disease Control and Prevention announced their resignations in recent days, citing what they described as growing political interference in the agency’s scientific work, particularly regarding vaccines.

    Two of them — Debra Houry, the CDC’s chief science and medical officer, and Demetre Daskalakis, who led the National Center for Immunization and Respiratory Diseases — stepped down on Wednesday, hours after the White House announced the firing of CDC Director Susan Monarez.


    Monarez, confirmed by the Senate in late July, was removed less than a month into her tenure. White House spokesperson Kush Desai said Monarez “was not aligned with the President’s agenda of Making America Healthy Again.” Monarez’s attorneys argue the dismissal is unlawful, asserting that only the president can remove a Senate-confirmed director.

    On Thursday, Jim O’Neill, the deputy secretary of the Department of Health and Human Services, was chosen to serve as acting CDC director, several White House officials confirmed to CBS News and KFF Health News. And in an internal email sent to CDC staffers that evening, HHS Secretary Robert F. Kennedy Jr. confirmed O’Neill as the acting CDC director without addressing Monarez’s departure.

    “I am committed to working with you to restore trust, transparency, and credibility to the CDC,” Kennedy told CDC employees, later writing that “President Trump and I are aligned on the commonsense vision for the CDC: Strengthen the public health infrastructure by returning to its core mission of protecting Americans from communicable diseases by investing in innovation to prevent, detect and respond to future threats.”

    Houry and Daskalakis said they had become increasingly uneasy about how vaccine policy was being handled. Both pointed to preparations for the Advisory Committee on Immunization Practices meeting, which recommends vaccine schedules.

    Houry said they feared “some decisions had been made before there was even the data or the science to support those. We are scientists, and that was concerning to us.”

    Daskalakis added that he was “very concerned that there’s going to be an attempt to relitigate vaccines that have already had clear recommendations with science that has been vetted,” which he warned could undermine public trust. “If you can’t attack access, then why not attack trust? And that’s what I think the playbook is,” he said.

    Both officials cited instances in which evidence reviews were altered or withdrawn. A CDC analysis of thimerosal, a vaccine preservative, was briefly posted before being taken down at the HHS’ direction. “If there’s something that doesn’t line up with the recommendations, then that information will be taken down, and it’s not there for the public to see for openness and transparency,” Houry said.

    The two also criticized what they described as a lack of direct communication between CDC scientists and HHS leadership. Daskalakis said his team was never invited to brief Kennedy on topics ranging from measles to COVID-19.

    When asked about Kennedy’s calls for “radical transparency,” Houry and Daskalakis described learning about changes to the COVID vaccine schedule for children not through internal channels but via social media.

    “The radical transparency manifested itself by a Twitter post, which is how Dr. Houry and I learned that the secretary had mandated the change in the children’s vaccine schedule for COVID,” Daskalakis recalled. “What is the background that led to that decision? And we were denied access to that information. So, I don’t think that that’s radically transparent,” Daskalakis said.

    CBS News and KFF Health News reached out to HHS for comment on some of the allegations made by Houry and Daskalakis but did not immediately hear back.

    Both officials said they had no jobs lined up when they resigned. Houry described the decision as an effort to raise the alarm about the direction of the agency.

    “For us, this was really sending out a bat signal,” Houry said. “We were the very senior scientists and career leaders at CDC. We thought this was the time to stand together and try to do what we could to raise the alarm around public health in our country.”

    Daskalakis said remaining at the CDC under current conditions would have made them complicit in what he called the “weaponization” of public health.

    “The safety has already been compromised. … We are flying blind in the U.S. already. If we continued … we would be complicit and would be facilitating the ability to go from flying blind to actively harming people,” he said.

    Houry emphasized the severity of the moment by noting that she left without a backup plan.

    “My leaving without a job was really just showing how dire the circumstances had become,” Houry said.

    Daskalakis said his decision was also shaped by his medical oath.

    “As a physician, I take the Hippocratic oath: First, do no harm. I am seeing ideology permeating science in a way that is going to harm children and adults. … I think we are seeing things that are happening that are making our country less prepared to be able to respond to the everyday pathogens … but also … to the next big thing.”

    Both also expressed concerns about their personal safety in the current climate.

    “The environment we live in … stoked by misinformation, especially from people considered by some to be health authorities, makes me worried for all of us in public health,” Daskalakis said. “I am concerned, but that’s part of our job … to be brave and continue to speak the truth even when we are outside of the CDC.”

    The resignations came weeks after a shooting outside the CDC’s Atlanta headquarters, which law enforcement linked to COVID misinformation.

    Houry said the White House response to the shooting was muted. Kennedy toured the site but later gave an interview expressing distrust of experts. “That was after the attack. It was based on COVID misinformation. So this is when we were trying to build trust,” she said.

    Daskalakis added that while Kennedy later described mass shootings as a public health crisis, he believed the secretary should address misinformation as a root cause. “The misinformation about the COVID vaccine — that has been documented by the Georgia Bureau of Investigation” as the reason for the CDC shooting. “I would really recommend that the secretary actually do take his own advice and actually address the core problem that led to that shooting as well,” he said.

    He also noted that the CDC’s gun violence prevention programs had been sharply reduced. “We talk about violence as a public health problem. It is, and there’s things we can do to prevent it. Unfortunately, the majority of that program, the staff are terminated,” he said.

    The firings and resignations have sparked calls for oversight. Independent Sen. Bernie Sanders of Vermont called for a bipartisan investigation, Democratic Sen. Patty Murray of Washington urged Kennedy’s removal, and Republican Sen. Bill Cassidy of Louisiana — who voted to confirm Kennedy’s appointment as HHS secretary — said the developments would “require oversight.”

    The events come as the FDA narrowed eligibility for updated COVID vaccines to older adults and people with risk factors for severe COVID.


    KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF. Subscribe to KFF Health News’ free Morning Briefing.

    This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.

    Céline Gounder, KFF Health News

    Source link

  • Policy changes are needed to address health inequities, IBX forum speakers say

    Policy changes are needed to address health inequities, IBX forum speakers say

    Level the playing field.

    That was the message of the “Catalyzing Change” event hosted by the Independence Blue Cross Foundation on Tuesday at the Kimmel Center. Attempt to right the wrongs built up by years of racial and gender discrimination in the health care system, so that the next generation doesn’t have to deal with those same issues.


    MOREGreater diversity among organ donors increases the possibility that people on waiting lists find good matches


    It’s part of an ongoing effort to educate the public and emphasize to those who control the purse strings how critical this is.

    “The important thing is to level the playing field so everybody can participate,” IBX Foundation President Lorina Marshall-Blake said. “We have to find a way for them to all be at the table.

    “It shouldn’t matter your race, creed, gender, sexual orientation. Stop talking about what you’re going to do and do something. … Make sure those who don’t have it will have it.”

    Her remarks followed two panel discussions that detailed the barriers at the local and national levels. The first featured three health care professionals who talked about everything from the way health care workers are assessed, to the joys of working with people from birth to death, to the fact that only one penny of every dollar given philanthropically goes to nurses. 

    “I think we’re worth more than that given our value and our mission,” said Roberta Waite, dean and professor at Georgetown School of Nursing, who was joined on the panel by Eliza E. Heppner, acting Deputy Associate Administrator for the Health, Resources and Services Administration, and Dr. Leon McCrea II, vice dean for educational affairs at Drexel University. “We have inequity right now because that’s what we have designed.

    “That’s what our policies have to bear. We have an obligation to look at it.”

    Following that came a national panel featuring Anna Heard, senior policy analyst for the National Governors Association and Gindhar Maliya, senior policy officer, of the Robert Wood Johnson Foundation. They talked about the obstacles faced in overcoming inequity, especially in today’s polarized political climate.

    Health Equity IBX 2Jon Marks/For PhillyVoice

    Roberta Waite, dean of Georgetown School of Nursing; Leon McCrea II, vice dean for educational affairs at Drexel University; Eliza Heppner, acting deputy health administrator for the Health Resources and Services Administration; and TaRhonda Thomas, a 6ABC reporter, take part in a panel discussion at the ‘Catalyzing Change’ health care forum hosted by the IBX Foundation on Tuesday.

    “Our policies have been fundamental to racial inequities dating back to slavery and Jim Crow,” said Maliya. “States are laboratories of democracy sometimes for better or worse.

    “Every state has increased access to health care and there’s evidence to show it is good investment. 

    “But when it comes to the focus on DEI (Diversity, Equity and Inclusion) there is a concerted, very well-funded effort in this country to portray it as divisive, illegal and un-American. Our people are dedicated to show that’s a misconception. When DEI works, it has potential to benefit all of us.”

    Stephen P. Fera, executive vice president of public affairs at IBX, said things need to change now. He noted the IBX Foundation expects to have awarded more than $85 million by the end of the year, dating back to its inception in 2011. 

    “What we do with this is critical,” Fera said. “If we don’t, we’ll be having the same conversation three, five or more years from now with no better results for the health care system.

    “We’d better get busy.”

    Otherwise, the panels stressed, the playing field will continue being more and more uneven.

    Jon Marks, PhillyVoice Contributor

    Source link

  • ‘Boy Meets World’ star Danielle Fishel encourages getting mammograms after her early diagnosis of breast cancer

    ‘Boy Meets World’ star Danielle Fishel encourages getting mammograms after her early diagnosis of breast cancer

    Danielle Fishel, who starred as Topanga Lawrence on the ’90s sitcom “Boy Meets World,” revealed Monday that she has been diagnosed with breast cancer.

    In the latest episode of “Pod Meets World,” the podcast Fishel hosts with former co-stars Rider Strong and Will Friedle, she discussed her journey with ductal carcinoma in situ, an early form of breast cancer.

    “It is very, very, very early,” Fishel, 43, said on the podcast. “It’s technically Stage 0. To be specific, just because I like too much information all the time, I was diagnosed with high-grade DCIS with microinvasion.”

    DCIS is a non-invasive or pre-invasive breast cancer, according to the American Cancer Society, meaning the cells that line the milk ducts in the breast have changed to cancer cells, but they have not spread through the walls of the ducts into the nearby breast tissue. The microinvasive aspect of Fishel’s diagnosis means that there is no invasive focus that measures more than 1 millimeter.

    About 20% of breast cancers are DCIS, according to Johns Hopkins Medicine. Nearly all women with DCIS can be cured, usually through surgery — either breast-conserving surgery or a mastectomy. Radiation and medication is also sometimes used, but chemotherapy is not needed. Fishel said she’s met with multiple doctors, and that she’ll be having surgery to remove it.

    DCIS does not involve specific symptoms like a lump or breast pain, according to Johns Hopkins. Once the cancerous cells begin to invade the milk duct, there might be itching or the formation of a sore. Most cases are diagnosed in a mammogram before any symptoms appear.

    “The only reason I caught this cancer when it is still Stage 0 is because the day I got my text message that my yearly mammogram had come up, I made the appointment,” Fishel said. “They found it so, so, so early that I’m going to be fine. And so, I want to share this because I hope that it will encourage anyone to get in there. If it’s time for your appointment, if you’ve never had an appointment before, get in there.”

    Fishel was a centerpiece of the Philly-set sitcom “Boy Meets World,” which aired from 1993-2000, as well as its spinoff “Girl Meets World,” which aired for three seasons starting in 2014 and featured the breakout acting performance of Bucks County native pop star Sabrina Carpenter. More recently, Fishel filmed episodes for the NBC sitcom “Lopez vs. Lopez.” She noted on the podcast that her diagnosis may affect her upcoming work.

    Franki Rudnesky

    Source link

  • Biden announces $150 million in research grants as part of his ‘moonshot’ push to fight cancer

    Biden announces $150 million in research grants as part of his ‘moonshot’ push to fight cancer

    NEW ORLEANS (AP) — President Joe Biden is zeroing in on the policy goals closest to his heart now that he’s no longer seeking a second term, visiting New Orleans on Tuesday to promote his administration’s “moonshot” initiative aiming to dramatically reduce cancer deaths.

    The president and first lady Jill Biden toured medical facilities that receive federal funding to investigate cancer treatments at Tulane University. Researchers used a piece of raw meat to demonstrate how they are working to improve scanning technology to quickly distinguish between healthy and cancerous cells during surgeries.

    The Bidens then championed the announcement of $150 million in awards from the Advanced Research Projects Agency for Health. Those will support eight teams of researchers around the country working on ways to help surgeons more successfully remove tumors from people with cancer. It brings the total amount awarded by the agency to develop breakthrough treatments for cancers to $400 million.

    Cancer surgery “takes the best surgeons and takes its toll on families,” Biden said. He said the demonstration of cutting-edge technology he witnessed would offer doctors a way to visualize tumors in real time, reducing the need for follow-on surgeries.

    “We’re moving quickly because we know that all families touched by cancer are in a race against time,” Biden said.

    The teams receiving awards include ones from Tulane, Dartmouth College, Johns Hopkins University, Rice University, the University of California, San Francisco, the University of Illinois Urbana-Champaign, the University of Washington and Cision Vision in Mountain View, California.

    Before he leaves office in January, Biden hopes to move the U.S. closer to the goal he set in 2022 to cut U.S. cancer fatalities by 50% over the next 25 years, and to improve the lives of caregivers and those suffering from cancer.

    “I’m a congenital optimist about what Americans can do,” Biden said. “There’s so much that we’re doing. It matters”

    Experts say the objective is attainable — with adequate investments.

    “We’re curing people of diseases that we previously thought were absolutely intractable and not survivable,” said Karen Knudsen, CEO of the American Cancer Society and the American Cancer Society Cancer Action Network.

    Cancer is the second-highest killer of people in the U.S. after heart disease. This year alone, the American Cancer Society estimates that 2 million new cases will be diagnosed and 611,720 people will die of cancer diseases.

    Still, “if all innovation ended today and we could just get people access to the innovations that we know about right now, we think we could reduce cancer mortality by another 20 to 30%,” Knudsen said.

    The issue is personal enough for Biden that, in his recent Oval Office address about bowing out of the 2024 campaign, the president promised to keep fighting for “my cancer moonshot so we can end cancer as we know it.”

    “Because we can do it,” Biden said then.

    He said in that speech that the initiative would be a priority of his final months in office, along with working to strengthen the economy and defend abortion rights, protecting children from gun violence and making changes to the Supreme Court, which he called “extreme” in its current makeup during a recent event.

    Both the president and first lady have had lesions removed from their skin in the past that were determined to be basal cell carcinoma, a common and easily treated form of cancer. In 2015, their eldest son, Beau, died of an aggressive brain cancer at age 46.

    “It’s not just personal,” Biden said Tuesday. “It’s about what’s possible.”

    Advertisement

    The president’s public schedule has been much quieter since he left the race and endorsed Vice President Kamala Harris, making Tuesday’s trip stand out.

    Advocates have praised Biden for keeping the spotlight on cancer, bringing stakeholders together and gathering commitments from private companies, nonprofit organizations and patient groups.

    They say that the extra attention the administration has paid has put the nation on track to cut cancer death rates by at least half, preventing more than 4 million deaths from the disease, by 2047. It has done so by bolstering access to cancer treatments and reminding people of the importance of screening, which hit a setback during the coronavirus pandemic.

    “President Biden’s passion and commitment to this effort has made monumental differences for the entire cancer community, including those who are suffering from cancer,” said Jon Retzlaff, the chief policy officer at the American Association for Cancer Research.

    Looking ahead, Retzlaff said, “The No. 1 thing is for us to see robust, sustained and predictable annual funding support for the National Institutes of Health. And, if we see that through NIH and through the National Cancer Institute, the programs that have been created through the cancer moonshot will be allowed to continue.”

    Initiatives under Biden include changes that make screening and cancer care more accessible to more people, said Knudsen, with the American Cancer Society.

    For instance, Medicare has started to pay for follow-up colonoscopies if a stool-based test suggests cancer, she said, and Medicare will now pay for navigation services to guide patients through the maze of their cancer care.

    “You’ve already paid for the cancer research. You’ve already paid for the innovation. Now let’s get it to people,” Knudsen said.

    She also said she’d like to see the next administration pursue a ban on menthol-flavored cigarettes, which she said could save 654,000 lives over the next 40 years.

    Scientists now understand that cancer is not a single disease, but hundreds of diseases that respond differently to different treatments. Some cancers have biomarkers that can be targeted by existing drugs that will slow a tumor’s growth. Many more targets await discovery.

    “We hope that the next administration, whoever it may be, will continue to keep the focus and emphasis on our national commitment to end cancer as we know it,” said Dr. Crystal Denlinger, CEO of the National Comprehensive Cancer Network, a group of elite cancer centers.

    Will Weissert, Carla K. Johnson and Associated Press

    Source link

  • Penn Medicine to open new proton therapy center in University City

    Penn Medicine to open new proton therapy center in University City

    Penn Medicine will open a fourth proton therapy center, expanding its ability to provide patients with the non-invasive cancer treatment that is associated with fewer side effects than other cancer treatments.

    Penn Medicine is building the new facility at Penn Presbyterian Medical Center, at 51 N. 39th St. in University City, and refurbishing its original Roberts Proton Therapy Center that opened in 2010 in the Perelman Center for Advanced Medicine, 3400 Civic Center Blvd., also in University City. The project will cost approximately $317 million, Kevin Mahoney, CEO of the University of Pennsylvania Health System, told the Philadelphia Business Journal. The new center, slated to open in 2027, will be built next to Penn Presbyterian.


    MORE: After seeing a high-speed, 3-car crash in Vermont, a Temple Hospital resident rushed to aid the people injured


    The Roberts Proton Therapy Center treats more than 100 patients daily and is the largest center in the world for proton and conventional radiation therapy. Penn Medicine has two other proton therapy centers, one that opened in Lancaster in 2022 and another at Virtua Health’s hospital in Voorhees, Camden County, that opened in 2023.

    There are 45 proton centers in the United States, according to the National Association for Proton Therapy.

    Proton therapy, a type of radiation therapy also known as proton beam therapy, uses the positively-charged particles to destroy cancer cells, causing little or no damage to surrounding tissue. Doctors have more control with proton therapy and can therefore use higher doses of radiation.

    Because it is more precise than other types of cancer treatment, proton therapy can target tumors near organs. It is used when possible in children with cancer to reduce the amount of damage to healthy tissue. Proton therapy can also treat cancer that recurs after other radiation treatment.

    Penn Medicine touts the treatment as less-invasive and having fewer side effects than other cancer therapies. A 2020 study showed that patients treated with proton therapy were less likely to experience severe side effects than patients treated with traditional radiation. Proton therapy can be used in combination with chemotherapy and other radiation treatments.

    Most insurance plans in the U.S., including Medicare, cover proton therapy.

    Courtenay Harris Bond

    Source link

  • Toxic metals including lead and arsenic found in multiple tampon brands

    Toxic metals including lead and arsenic found in multiple tampon brands

    Tampons from many different brands may contain potentially harmful metals, a new study found.

    Researchers assessed tampons from 14 different brands and found “measurable concentrations” of all 16 metals that they tested for, according to the study, published last week in the Environment International journal. Metals that are considered toxic, including lead, arsenic and cadmium, were found in some of the tampons.

    Exposure to metals has been found to increase the risk of dementia, infertility, diabetes and cancer, according to a news release from the University of California, Berkeley. Metals can also damage the liver, kidneys, brain, fetal development and maternal health. They can also harm the cardiovascular, nervous and endocrine systems. 

    Tampons can contain metals from agricultural or manufacturing processes. For example, the cotton material could absorb the metals from water, air, soil or a nearby contaminant. Or companies may intentionally add metals during the manufacturing process as part of a pigment or antibacterial agent, according to researchers.

    Tampons serve as a “particular concern” when it comes to potential sources of exposure to chemicals and metals, according to UC Berkeley, because the skin of the vagina has a higher potential for chemical absorption. Furthermore, a large portion of the population uses tampons — between 52% and 86% of people in the United States who menstruate use them, usually for hours at a time, according to researchers. 

    “Despite this large potential for public health concern, very little research has been done to measure chemicals in tampons,” Jenni A. Shearston, the lead author of the study and a postdoctoral scholar at the UC Berkeley School of Public Health, said in the release. “To our knowledge, this is the first paper to measure metals in tampons. Concerningly, we found concentrations of all metals we tested for, including toxic metals like arsenic and lead.”

    In the study, researchers evaluated 30 tampons from 14 different brands for the following 16 metals: arsenic, barium, calcium, cadmium, cobalt, chromium, copper, iron, manganese, mercury, nickel, lead, selenium, strontium, vanadium and zinc. Study authors did not specify which tampon brands they tested, but said that they selected products listed as “top sellers” on a major online retailer as well as “store-brand” products. The products were purchased between September 2022 and March 2023 in New York City; London, England; and Athens, Greece. 

    Metal concentrations varied based on where the tampons were purchased, whether they were organic, and whether they were store-brand or name-brand products. But metals were present in all types of tampons and no category had consistently lower metal concentrations. Lead was found in all tampons tested, researchers say. Lead concentrations were higher in non-organic tampons, but arsenic was higher in organic tampons, the study found. 

    The study authors point out that the governing bodies in the the United States, United Kingdom and the European Union  where they purchased tampons for the study — have regulations surrounding tampons that are “not extensive” and they do not require regular product testing. In the United States, the Food and Drug Administration classifies tampons as medical devices and regulates their safety, but there is no requirement to test them for chemical contaminants. The researchers hope the findings of this study will help contribute to change in the industry.

    “I really hope that manufacturers are required to test their products for metals, especially for toxic metals,” Shearston said. “It would be exciting to see the public call for this, or to ask for better labeling on tampons and other menstrual products.”

    Franki Rudnesky

    Source link

  • You Can Get Ozempic at Med Spas – but Experts Warn It May Not Be Legit – POPSUGAR Australia

    You Can Get Ozempic at Med Spas – but Experts Warn It May Not Be Legit – POPSUGAR Australia

    As an American woman living in the year 2024, I’m constantly hearing about Ozempic. For the past year, it seems like every week, someone I know says they’ve started the diabetes medication-turned-weight loss super drug – and when I’m not, I’m bombarded with the conversation on social media. Not to mention the ads – I see them on the New York City subway, on Instagram (RIP my algorithm for researching this story), and, well, everywhere else.

    Since Ozempic has exploded onto the weight-loss scene, it can seem both ubiquitous and scarce, creating confusion about who can get it and how. Initially developed by Novo Nordisk to treat type 2 diabetes, its off-label usage has morphed into a phenomenon now associated with quick and extreme weight loss, leading to shortages for some diabetic patients. The company also makes a similar semaglutide drug called Wegovy, which has been approved by the Food and Drug Administration for weight loss.

    You need a doctor’s prescription to get the drugs, which are extremely expensive if insurance doesn’t cover the cost – out of pocket, it’s about $935 per month for Ozempic or $1,350 for Wegovy. Generally, prescriptions are reserved for people who have diabetes or are prediabetic with other underlying conditions. Yet medical spas (nonsurgical, aesthetic medical centers that usually offer injectables, lasers, or other procedures), online pharmacies, and telehealth services are blasting social media with ads offering the hard-to-get pharmaceuticals – raising questions about what’s being offered and if it’s legit.

    After I called many med spas in different states – including California, West Virginia, and Louisiana – to inquire about getting on Ozempic, the answer that emerged was: there’s no way to know what you’re getting.

    Related: I Thought Weight-Loss Drugs Were the Answer – Until They Sent Me to the ER

    Ozempic, Wegovy, and other drugs like Saxenda (liraglutide) and Mounjaro (tirzepatide) are part of a class of drugs called glucagon-like peptide 1 (GLP-1) agonists. They imitate the hormone GLP-1, which stimulates the body to produce insulin to control blood sugar. In practice, they make you feel full faster and longer, so you eat less.

    Ozempic and Wegovy are listed on FDA’s Drug Shortages list, as is Saxenda. The diabetes drug Mounjaro and the obesity shot Zepbound are also facing shortages in certain dosages. Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus tablets, which are all under patent without a generic option. So how are some people getting it, especially when they don’t have diabetes or other conditions, including a high BMI, that doctors usually require to prescribe? And is accessing it through avenues like med spas and online pharmacies legal and safe?

    The answers can be murky.

    When I called med spas and weight-loss clinics, most do require an in-person consultation, unlike online pharmacies. When I asked if what they were offering was real – brand name Ozempic or Wegovy – I was told yes. But when I asked how they could offer it so cheaply (as low as $200 per month in some cases), I was told it was because they got the product from a lab or pharmacy. When I asked who would do the evaluation to see if I qualified to take it, I was told it could be a nurse or a doctor, but it was not specified. Some places said I would need to book follow-up visits to adjust the dosage. But after talking to several of these institutions, it’s clear there is no uniform protocol.

    It’s likely that many of these med spas and clinics are getting their semaglutide drugs from compounding pharmacies, which make customized drugs. In times of shortages, the FDA allows these pharmacies to offer altered versions. Some versions may simply take out potential allergens or irritating ingredients, or tailor individual dosages. But some may be counterfeit drugs, or ones made from unknown or dangerous active ingredients. There is no federal oversight for compounding pharmacies; they are regulated on the state level.

    “I do not know what’s in the shot, I do not know where they get it.”

    “Compounded drugs pose a higher risk to patients than FDA-approved drugs because compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality. Compounded drugs also lack an FDA finding of manufacturing quality before such drugs are marketed,” FDA spokeswoman Amanda Hills wrote in an email.

    From Aug. 8, 2021, through March 31, the agency received 209 reports of adverse events and 110 complaints in association with compounded semaglutide drugs.

    Although the reactions may be similar to those logged for the brand name, FDA-approved semaglutide products, the agency can’t dismiss other factors “such as differences in ingredients and formulation between FDA-approved and compounded semaglutide products,” Hills wrote, adding that the data is limited because “compounding pharmacies generally do not submit adverse event reports to the FDA.”

    In addition, some facilities offering semaglutide are reportedly using something entirely different. Compounded drugs made with semaglutide sodium and semaglutide acetate, which are salt forms that are not semaglutide, the active ingredient in Ozempic, Rybelsus, and Wegovy, have been reported, prompting the agency to issue multiple warnings. As Hills wrote: “These salt forms are not the active ingredients of any FDA-approved medication, and the FDA is not aware of any basis for compounding a drug using these semaglutide salts that would meet federal requirements. In addition, it is not known whether semaglutide salts are safe or effective.”

    Last year, Novo Nordisk announced it was taking action against med spas, pharmacies, and wellness and weight-loss centers that offer compounded versions of semaglutide, and has filed at least a dozen lawsuits. Eli Lilly, the maker of Mounjaro, has also launched several lawsuits against similar providers for marketing and selling compounded versions of the drug’s active ingredient, tirzepatide. Mississippi’s State Board of Medical Licensure now prohibits prescribing, dispensing, or administrating compounded semaglutide for weight loss, citing safety concerns, but laws vary from state to state. Customers can consult the FDA’s BeSafeRx campaign to navigate buying drugs safely online.

    Given how much is still unregulated when it comes to compounded versions of these drugs, medical experts discourage getting the drugs outside of a licensed physician’s supervision and care. Zhaoping Li, MD, PhD, a professor of medicine and chief of the Division of Clinical Nutrition at the University of California at Los Angeles, describes weight-loss drugs coming from med spas like this: “I do not know what’s in the shot, I do not know where they get it.”

    “We’re talking about prescription drugs,” she adds. “The reason it’s prescription is because it does carry significant risk and also benefits. We are now learning more and more possible side effects.”

    Side effects of these drugs include nausea, vomiting, diarrhea, burping, and constipation; abdominal discomfort and pain; injection site reactions; fatigue; hair loss; gallbladder problems; low blood sugar; acute kidney damage; diabetic retinopathy (damage to the eye’s retina); and suicidal behavior or thinking, according to the FDA.

    Li also emphasizes that GLP-1 agonists work differently in different people. “There are people not losing weight, and they’re also people losing a lot of weight, particularly losing muscle. That is a significant concern for elderly in particular,” she says. She urges patients taking these medications to tell their doctor if they are feeling weak.

    She adds that some people “have significant depression with those shots,” noting that some patients lose weight as fast as those who undergo bariatric surgery, which can also result in increased depression, anxiety, and suicidal ideation in patients. However, she says, “we have guidelines about how to take care of patients after bariatric surgery, but we have nothing for people taking GLP-1 treatments, especially at a med spa or water therapy place.”

    At UCLA’s Nutrition Clinic, the drugs are prescribed by a doctor, who also integrates a lifestyle regime that tracks diet and exercise and includes regular follow-up visits.

    Li reiterated that there’s no way to know what is in the injections given out at med spas. She also warns that these places don’t offer any standardized practice of care for patients while they take the drugs. 

    After reading about, calling, and interviewing experts and facilities providing these weight-loss shots, I – like the FDA and the head of nutrition at UCLA – cannot tell you exactly what is in them. Hopefully, the drugs become more accessible to the people who need them. In the meantime, if something sounds too good to be true, there may be a reason for it.


    Soo Youn is a journalist who covers pop culture, business, gender and technology. She has worked at Reuters and ABC News and has written for The Washington Post, The New York Times, The Guardian, NBC News, Teen Vogue and other publications.


    Soo youn

    Source link

  • Drinking apple cider vinegar daily may be linked with weight loss, study finds

    Drinking apple cider vinegar daily may be linked with weight loss, study finds

    Apple cider vinegar makes for a tasty salad dressing or marinade, but new research has found that it also could be useful in boosting weight loss efforts.

    Daily consumption of small amounts of apple cider vinegar — which is made from fermented apple juice and contains the active ingredient acetic acid — may aid weight management in people who are overweight or obese, according to a study published earlier this month in BMJ Nutrition, Prevention & Health. 

    The small study focused on 120 people from Lebanon, ages 12 to 25 years, who had obesity or were overweight. Some participants were randomly assigned to drink either 5, 10 or 15 milliliters of apple cider vinegar diluted in a cup of water once a day, first thing in the morning, for a period of 12 weeks. Other participants were given a placebo liquid to drink each day.

    Compared with the people given the placebo, the participants who drank the apple cider vinegar lost “significant” amounts of weight, losing an average 15 pounds over the course of the study. The apple cider vinegar drinkers also saw reductions in BMI. Those who drank the largest amount of apple cider vinegar, 15 milliliters, experienced the largest decreases in weight and BMI after 12 weeks. 

    The apple cider vinegar drinkers also saw significant reductions in waist and hip measurements and body fat ratio compared with the placebo. These reductions were similar regardless of dose, suggesting the effect didn’t depend on the quantity, the researchers say.

    There were also improvements in metabolic markers — which are used to gauge someone’s overall health — such as levels of blood glucose, triglycerides and total cholesterol.

    “These results suggest that apple cider might have potential benefits in improving metabolic parameters related to obesity and metabolic disorders in obese individuals,” the study authors said. “The results might contribute to evidence-based recommendations for the use of (apple cider vinegar) as a dietary intervention in the management of obesity.”

    The authors note that there are some limitations, including the study’s small sample size and short 12-week period, which is not enough to gauge possible longterm side effects.

    Furthermore, while apple cider vinegar has shown to have several possible health benefits — like killing harmful bacteria, managing diabetes and improving heart health — it is not necessarily a “magic pill,” registered dietitian nutritionist Michelle Routhenstein told Healthline.

    “(Apple cider vinegar) needs to be looked at in conjunction with overall diet and physical activity, as well as stress and sleep management, to have a significant long-lasting impact,” Routhenstein said.

    Franki Rudnesky

    Source link

  • Philly’s health commissioner will step down after nearly three years on the job

    Philly’s health commissioner will step down after nearly three years on the job


    After more than two years serving as Philadelphia’s health commissioner, Dr. Cheryl Bettigole is resigning. Bettigole’s last day in the role will be Feb. 15.

    Mayor Cherelle Parker’s administration did not provide a reason for Bettigole’s resignation. Deputy health commissioner Frank A. Franklin will serve in the interim while a “nationwide search” for a successor commences.

    “Dr. Bettigole has served our City and citizens well as Health Commissioner, and we thank her for all her public service to Philadelphia,” said Parker. “The Health Department performs vital services for our residents, from primary care to vaccinations to alerting Philadelphia when communicable diseases are spreading, among many services, and we embrace its mission.”

    Bettigole officially took on the health commissioner position in November 2021 after her predecessor, Dr. Thomas Farley, was marred by a scandal. The scandal involved the mishandling of the human remains of victims in the 1985 MOVE bombing in West Philadelphia.

    The beginning of Bettigole’s tenure coincided with the surge of the delta variant of COVID-19. In April 2022, Bettigole announced the return of an indoor mask requirement, which Philly businesses and residents pushed back against in the form of a lawsuit. The city reversed the mandate a mere four days later.

    Other noteworthy initiatives under Bettigole include a five-year plan aimed at improving access to primary care and preparing for public health emergencies, and efforts to create models of care for displaced evacuees and migrants.

    “It has been an honor and a privilege to serve as health commissioner for the past 3 years,” said Bettigole. “I am immensely proud of the work that has taken place in the Health Department and am profoundly grateful for the professionalism, expertise, and dedication found within the employees who I was fortunate to serve with.”



    Chris Compendio

    Source link

  • Pig Kidney Works 2 Months In Donated Body, Raising Hope For Animal-Human Transplants

    Pig Kidney Works 2 Months In Donated Body, Raising Hope For Animal-Human Transplants

    NEW YORK (AP) — Dozens of doctors and nurses silently lined the hospital hallway in tribute: For a history-making two months, a pig’s kidney worked normally inside the brain-dead man on the gurney rolling past them.

    The dramatic experiment came to an end Wednesday as surgeons at NYU Langone Health removed the pig kidney and returned the donated body of Maurice “Mo” Miller to his family for cremation.

    It marked the longest a genetically modified pig kidney has ever functioned inside a human, albeit a deceased one. And by pushing the boundaries of research with the dead, the scientists learned critical lessons they’re preparing to share with the Food and Drug Administration -– in hopes of eventually testing pig kidneys in the living.

    “It’s a combination of excitement and relief,” Dr. Robert Montgomery, the transplant surgeon who led the experiment, told The Associated Press. “Two months is a lot to have a pig kidney in this good a condition. That gives you a lot of confidence” for next attempts.

    Montgomery, himself a recipient of a heart transplant, sees animal-to-human transplants as crucial to ease the nation’s organ shortage. More than 100,000 people are on the national waiting list, most who need a kidney, and thousands will die waiting.

    So-called xenotransplantation attempts have failed for decades — the human immune system immediately destroyed foreign animal tissue. What’s new: Trying pigs genetically modified so their organs are more humanlike.

    Surgeons remove a gene-edited transplanted pig kidney from the body of Maurice “Mo” Miller at NYU Langone Health in New York on Sept. 13, 2023.

    Some short experiments in deceased bodies avoided an immediate immune attack but shed no light on a more common form of rejection that can take a month to form. Last year, University of Maryland surgeons tried to save a dying man with a pig heart –- but he survived only two months as the organ failed for reasons that aren’t completely clear. And the FDA gave Montgomery’s team a list of questions about how pig organs really perform their jobs compared to human ones.

    Montgomery gambled that maintaining Miller’s body on a ventilator for two months to see how the pig kidney worked could answer some of those questions.

    “I’m so proud of you,” Miller’s sister, Mary Miller-Duffy, said in a tearful farewell at her brother’s bedside this week.

    Miller had collapsed and was declared brain-dead, unable to donate his organs because of cancer. After wrestling with the choice, Miller-Duffy donated the Newburgh, New York, man’s body for the pig experiment. She recently got a card from a stranger in California who’s awaiting a kidney transplant, thanking her for helping to move forward desperately needed research.

    “This has been quite the journey,” Miller-Duffy said as she and her wife Sue Duffy hugged Montgomery’s team.

    On July 14, shortly before his 58th birthday, surgeons replaced Miller’s own kidneys with one pig kidney plus the animal’s thymus, a gland that trains immune cells. For the first month, the kidney worked with no signs of trouble.

    But soon after, doctors measured a slight decrease in the amount of urine produced. A biopsy confirmed a subtle sign that rejection was beginning –- giving doctors an opportunity to tell if it was treatable. Sure enough, the kidney’s performance bounced back with a change in standard immune-suppressing medicines that patients use today.

    “We are learning that this is actually doable,” said NYU transplant immunologist Massimo Mangiola.

    The researchers checked off other FDA questions, including seeing no differences in how the pig kidney reacted to human hormones, excreted antibiotics or experienced medicine-related side effects.

    “It looks beautiful, it’s exactly the way normal kidneys look,” Dr. Jeffrey Stern said Wednesday after removing the pig kidney at the 61-day mark for closer examination.

    The next steps: Researchers took about 180 different tissue samples –- from every major organ, lymph nodes, the digestive tract –- to scour for any hints of problems due to the xenotransplant.

    Experiments in the deceased cannot predict that the organs will work the same in the living, cautioned Karen Maschke, a research scholar at the Hastings Center who is helping develop ethics and policy recommendations for xenotransplant clinical trials.

    But they can provide other valuable information, she said. That includes helping to tease out differences between pigs with up to 10 genetics changes that some research teams prefer — and those like Montgomery uses that have just a single change, removal of a gene that triggers an immediate immune attack.

    “Why we’re doing this is because there are a lot of people that unfortunately die before having the opportunity of a second chance at life,” said Mangiola, the immunologist. “And we need to do something about it.”

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link